Medications for Opioid Use Disorders: Which One is Best?
Round Table Facilitator(s)
Zachary Talbott, CCS
Chief Clinical Officer
ReVIDA Recovery Centers
There are currently three medications approved by the Food & Drug Administration (FDA) for the treatment of opioid use disorder: methadone, buprenorphine, and naltrexone. Efficacy of and response to each medication can vary from patient to patient, and each medication has its place in the national response to the opioid crisis. Each medication is not, however, equal in terms of research and evidence. So, which medication is better? This Hot Topic Roundtable is designed to facilitate a discussion around the three FDA-approved medications, including their differences, similarities, and the evidence base that supports each of their use in treatment.
- Describe the effectiveness of each available mediation in treating opioid use disorder
- Describe benefits and challenges of using FDA approved mediations
- Name medications for the treatment of opioid use disorders